Compare TSCO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSCO | DVA |
|---|---|---|
| Founded | 1938 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 14.9B |
| IPO Year | 1996 | 2003 |
| Metric | TSCO | DVA |
|---|---|---|
| Price | $33.07 | $181.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 4 |
| Target Price | $53.05 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 8.7M | 552.1K |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | ★ 0.98 | N/A |
| EPS | 1.00 | ★ 6.86 |
| Revenue | ★ $15,524,046,000.00 | $13,643,069,000.00 |
| Revenue This Year | $7.32 | $3.85 |
| Revenue Next Year | $6.01 | $3.07 |
| P/E Ratio | $34.00 | ★ $26.68 |
| Revenue Growth | 4.31 | ★ 6.46 |
| 52 Week Low | $28.36 | $101.00 |
| 52 Week High | $60.86 | $247.49 |
| Indicator | TSCO | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 42.41 |
| Support Level | $29.13 | $176.59 |
| Resistance Level | $36.50 | $202.63 |
| Average True Range (ATR) | 0.97 | 4.77 |
| MACD | -0.28 | 2.21 |
| Stochastic Oscillator | 10.94 | 71.79 |
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. As of March 2026, the company operated 2,435 of its namesake banners in 49 states, along with 206 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2025, revenue consisted of livestock, equine & agriculture (around 27%); companion animal (24%); seasonal & recreation (around 24%); truck, tool, & hardware (15%); and clothing, gift, and décor (10%).
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.